论文部分内容阅读
吉非替尼是一种酪氨酸激酶受体抑制剂,广泛用于晚期非小细胞肺癌的治疗,近年来国内有文献报道其不良反应,现摘要如下。1皮肤过敏男,82岁,因右下肺癌Ⅱ期给予吉非替尼0.25 g口服,9 d,服药1周后突发全身皮肤过敏,药疹遍布四肢,前胸及面部皮肤,且干燥发痒,停药后上述症状缓解,2次
Gefitinib is a tyrosine kinase receptor inhibitor, widely used in the treatment of advanced non-small cell lung cancer in recent years, the domestic literature reported adverse reactions, are summarized as follows. 1 skin allergy Male, 82 years old, given gefitinib 0.25g orally for stage II lung cancer in lower right lung, 9 days after treatment. Sudden systemic skin allergy, drug rash all over the extremities, chest and facial skin, dry and itchy , After stopping the above symptoms, 2 times